MAPK3 and lymphoma: Interestingly, pretreatment with the inhibitor of ERK1/2 activator, U0126, blocks the phosphorylation of ERK1/2 and attenuates SK053-induced apoptosis, implicating a role for ERK1/2 signaling in SK053-induced lymphoma cell death (Figure 6G, 6H).